2025-524277-16-00RecruitingPhase 1/2
A Phase 1 Study of Fentanyl Vaccine
Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- First submitted
- 20 Oct 2025
- Start date
- 26 Feb 2026
- Lead sponsor
- ARMR Sciences Inc.
- Diseases
- Depression
- EU CT number
- 2025-524277-16-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 130
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 64 for a Phase 1 study of a fentanyl vaccine. The record does not list further criteria.
- Age
- 18 to 64 years
- Sex
- All sexes can join
Read by machine on 9 Nov 2026.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Human Drug Research | Leiden | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.